We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going to take a look at where ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

On Tuesday, Viatris Inc (VTRS) stock saw a decline, ending the day at $11.32 which represents a decrease of $-0.01 or -0.09% from the prior close of $11.33. The stock opened at $11.33 and touched a ...

Viatris Inc (VTRS) reports a solid quarter with $3.8 billion in revenue and increased new product revenue expectations, despite challenges from global price regulations.

思路迪诊断七年潜心研发，“DR同步共检”技术推动肺癌诊疗取得重大进步,思路迪,肺癌,肿瘤,治疗 ...

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety ...

Viatris (VTRS) reported positive top-line results of Phase 3 study in Japan evaluating the safety and efficacy of EFFEXOR in adults ...

在其他近期新闻中，Viatris Inc.在财务和运营表现方面取得了重大进展。公司最近报告了强劲的2024年第二季度业绩，总收入达到38亿美元，运营收入增长2%。调整后的息税折旧及摊销前利润（EBITDA）上升至12亿美元，调整后每股收益（EPS）报告为0.69美元。这些积极结果使Viatris将2024年新产品收入预测提高到5亿至6亿美元之间。

We recently made a list of 10 Best NASDAQ Stocks Under $20 to Buy. In this piece, we will look at where Viatris Inc.

Novo Nordisk (NOV: N) has reached a settlement with Mylan Pharmaceuticals, part of Viatris (Nasdaq: VTRS), concluding a US ...

Novo Nordisk ($NVO) and Viatris ($VTRS) have agreed to settle a dispute over patents for Novo’s weight-loss drugs, Ozempic ...

Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...